ALECAlector, Inc.

Nasdaq alector.com


$ 5.05 $ -0.23 (-4.26 %)    

Monday, 05-Aug-2024 15:59:56 EDT
QQQ $ 437.97 $ -13.38 (-2.98 %)
DIA $ 386.91 $ -10.32 (-2.6 %)
SPY $ 518.58 $ -15.52 (-2.91 %)
TLT $ 98.76 $ 0.52 (0.53 %)
GLD $ 222.59 $ -2.86 (-1.27 %)
$ 5.06
$ 5.03 x 201
-- x --
-- - --
$ 3.66 - $ 8.90
609,614
na
474.68M
$ 0.72
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-08-2024 03-31-2024 10-Q
2 02-27-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 02-28-2023 12-31-2022 10-K
7 11-08-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 02-24-2022 12-31-2021 10-K
11 11-04-2021 09-30-2021 10-Q
12 08-03-2021 06-30-2021 10-Q
13 05-05-2021 03-31-2021 10-Q
14 02-25-2021 12-31-2020 10-K
15 11-10-2020 09-30-2020 10-Q
16 08-11-2020 06-30-2020 10-Q
17 05-13-2020 03-31-2020 10-Q
18 03-24-2020 12-31-2019 10-K
19 11-12-2019 09-30-2019 10-Q
20 08-12-2019 06-30-2019 10-Q
21 05-13-2019 03-31-2019 10-Q
22 03-26-2019 12-31-2018 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cantor-fitzgerald-reiterates-overweight-on-alector

Cantor Fitzgerald analyst Pete Stavropoulos reiterates Alector (NASDAQ:ALEC) with a Overweight.

 alector-announced-baseline-characteristics-data-for-the-invoke-2-study-confirm-a-representative-study-population-that-enables-testing-of-the-effects-of-a-novel-trem2-agonist-in-early-alzheimers-disease

Alector, Inc. (NASDAQ:ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced the presentati...

 cantor-fitzgerald-reiterates-overweight-on-alector

Cantor Fitzgerald analyst Pete Stavropoulos reiterates Alector (NASDAQ:ALEC) with a Overweight.

 hc-wainwright--co-reiterates-buy-on-alector-maintains-35-price-target

HC Wainwright & Co. analyst Andrew Fein reiterates Alector (NASDAQ:ALEC) with a Buy and maintains $35 price target.

 hc-wainwright--co-maintains-buy-on-alector-lowers-price-target-to-35

HC Wainwright & Co. analyst Andrew Fein maintains Alector (NASDAQ:ALEC) with a Buy and lowers the price target from $41 ...

 cantor-fitzgerald-reiterates-overweight-on-alector

Cantor Fitzgerald analyst Pete Stavropoulos reiterates Alector (NASDAQ:ALEC) with a Overweight.

 alector-q1-eps-038-beats-051-estimate-sales-1589m-beat-1480m-estimate

Alector (NASDAQ:ALEC) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(0.51) by 25...

 hc-wainwright--co-reiterates-buy-on-alector-maintains-41-price-target

HC Wainwright & Co. analyst Andrew Fein reiterates Alector (NASDAQ:ALEC) with a Buy and maintains $41 price target.

 recap-alector-q4-earnings
Recap: Alector Q4 Earnings
02/27/2024 21:50:25

 alector-q4-2023-gaap-eps-049-beats-077-estimate-sales-1519m-beat-964m-estimate

Alector (NASDAQ:ALEC) reported quarterly losses of $(0.49) per share which beat the analyst consensus estimate of $(0.77) by 36...

 earnings-scheduled-for-february-27-2024

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on rev...

 earnings-outlook-for-alector
Earnings Outlook For Alector
02/26/2024 16:01:30

 why-airspan-networks-shares-are-trading-higher-by-over-380-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Airspan Networks Holdings Inc. (NASDAQ: MIMO) shares rose sharply during Wednesday’s session after the company announ...

 why-alector-alec-stock-is-diving-today

Alector shares are trading lower by 14.9% during Wednesday's session. The company announced the pricing of a $75 million pu...

 solaredge-technologies-calavo-growers-fisker-and-other-big-stocks-moving-lower-on-wednesday

U.S. stocks traded lower, with the Nasdaq Composite falling more than 150 points on Wednesday.

 alector-announces-pricing-of-75m-public-offering-of-10869566-shares-of-common-stock

Alector, Inc. (NASDAQ:ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced the pricing of...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION